Kiniksa Pharmaceuticals International, plc business relationships
Companies named in Kiniksa Pharmaceuticals International, plc’s 10-K filed 2026-02-24, and public companies whose annual reports name Kiniksa Pharmaceuticals International, plc. Each link shows the sentence it came from. Scores are Engagemii’s AI visibility scores.
- AEO visibility
- 5.4 / 10
- AI naming
- 64 / 100 Top 1% in its category
- Agent readiness
- 25 / 100
- AI adoption
- 0 / 100
Named in Kiniksa Pharmaceuticals International, plc’s annual report 6
“Regeneron not obligated to accept our forecasts or purchase orders in certain circumstances and Regeneron may not have sufficient manufacturing capacity to meet our commercial or clinical demand for ARCALYST (including increased demand arising from our need to replace material lost to manufacturing...” SEC filing
“We also evenly split with Regeneron any proceeds received by us from any licensees, sublicensees and distributors in consideration for the sale, license or other disposition of rights with respect to ARCALYST, including upfront payments, milestone payments and royalties.” SEC filing
“In 2017, we licensed ARCALYST from Regeneron, which discovered and initially developed the drug.” SEC filing
“Collaboration expenses consist of Regeneron's share of the profit related to ARCALYST sales under the Regeneron Agreement and the cost of products sold under collaboration agreements.” SEC filing
“The Company entered into supply agreements with Regeneron to provide both clinical supply and commercial product (see Note 13).” SEC filing
“Under the Genentech License Agreement, Genentech has the right to assume manufacturing responsibilities for Genentech Licensed Products.” SEC filing
Companies whose annual reports name Kiniksa Pharmaceuticals International, plc 1
“(b) In connection with our license agreement with Kiniksa Pharmaceuticals, Ltd., we are entitled to receive 50% of Kiniksa's profits from sales of ARCALYST” SEC filing
Links are read automatically from SEC annual reports (10-K, 20-F, 40-F). In a hand check of random links, about 8 in 10 were real business relationships, so every link carries its source sentence.